APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
56 hedge funds and large institutions have $174M invested in Aptose Biosciences, Inc. in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
54% more call options, than puts
Call options by funds: $1.41M | Put options by funds: $918K
Holders
56
Holding in Top 10
3
Calls
$1.41M
Puts
$918K
Top Buyers
| 1 | +$27.1M | |
| 2 | +$19.1M | |
| 3 | +$10.1M | |
| 4 |
O
OrbiMed
New York
|
+$6.52M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$5.51M |
Top Sellers
| 1 | -$8.1M | |
| 2 | -$7.88M | |
| 3 | -$259K | |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$259K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$156K |